In this regard, KDM5C upregulation attenuates the anti-tumoral effects of LBX2-AS2 silencing in terms of the proliferation, migration, stemness, and apoptosis of ovarian cancer cells (Gu et al., 2021[45]). The gene discussed is KDM5C; the disease is ovarian cancer.